摘要
目的对瑞舒伐他汀与阿托伐他汀在治疗冠心病中的临床效果进行比较分析。方法 :选择我院在2016年1月—2017年12月收治的54例冠心病患者为研究对象,按照用药方案不同将其分为观察组与对照组,治疗过程中观察组服用瑞舒伐他汀治疗,对照组服用阿托伐他汀治疗,对用药后两组患者的病情改善情况及用药的不良反应发生率进行观察分析。结果相较于对照组的治疗总有效率(74.07%),观察组治疗总有效率(92.59%)更高;观察组用药期间不良反应发生率低于对照组,两组间比较差异均有统计学意义(P <0.05)。结论瑞舒伐他汀在临床中用于治疗冠心病患者,可更加显著的改善患者各项血脂水平,缓解其临床症状,起到更好的治疗效果。
Objective To compare the clinical efects of rosuvastatin and atorvastatin in the treatment of coronary heart disease. Methods Fifty-four patients with coronary artery disease who were admitted to our hospital from January 2016 to December 2017 were selected as the study subjects. They were divided into the observation group and the control group according to different medications. The observation group was treated with rosuvastatin during the treatment. The control group was treated with atorvastatin. The improvement of the patient＇s condition and the incidence of adverse drug reactions were observed and analyzed after treatment. Results Compared with the control group, the total efective rate （92.59%） was higher in the observation group than in the control group （74.07%）; The incidence of adverse reactions in the observation group was lower than that in the control group, and there was signifcant diference between the two groups （P 〈 0.05）. Conclusion Rosuvastatin is used to treat patients with coronary heart disease in clinical practice. It can signifcantly improve each patient＇s blood lipid levels, relieve their clinical symptoms, and play a better therapeutic efect.
作者
高淑华
GAO Shuhua(Department of Cardiology,People＇s Hospital of Xinzhou City,Xinzhou Shanxi 034000,China)
出处
《中国继续医学教育》
2018年第31期122-124,共3页
China Continuing Medical Education
关键词
瑞舒伐他汀
阿托伐他汀
冠心病
临床疗效
老年
血脂
rosuvastatin
atorvastatin
coronary heart disease
clinical efcacy
elderly
blood lipids
